One study suggests that reducing NOS2 expression alters the spatial orientation and density of lymphoid cells, particularly CD8 T cells within the tumor microenvironment and when NOS2 is depleted and COX2 is inhibited, tumor growth slows and the immune response enhances (Somasundaram et al., 2022). Here, NOS2 is linked to neoplasm.